Skip to main content
. 2022 Nov 21;21(3):135–141. doi: 10.1080/2090598X.2022.2148867

Figure 1.

Figure 1.

Forest plots depicting hazard ratios, their respective 95% confidence intervals, and p-values of the competing risks regression models testing the association between cancer-specific mortality (CSM), after adjustment for other cause mortality (OCM), and type and number of high-risk criteria in D’Amico high-risk prostate cancer (PCa) patients treated with external beam radiotherapy. All analyses were stratified according to race/ethnicity.